+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genomic Biomarker Market by Product Type (Instruments, Reagents & Kits, Services), Technology (Mass Spectrometry, Microarray, Next-Generation Sequencing), Application, End User, Biomarker Type - Global Forecast 2025-2030- Product Image
Genomic Biomarker Market by Product Type (Instruments, Reagents & Kits, Services), Technology (Mass Spectrometry, Microarray, Next-Generation Sequencing), Application, End User, Biomarker Type - Global Forecast 2025-2030- Product Image
Sale

Genomic Biomarker Market by Product Type (Instruments, Reagents & Kits, Services), Technology (Mass Spectrometry, Microarray, Next-Generation Sequencing), Application, End User, Biomarker Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977839
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Genomic Biomarker Market is experiencing substantial momentum as healthcare providers and industry leaders increasingly integrate biomarkers into disease management, drug development, and clinical workflows. Advances in sequencing technology and bioinformatics are fostering broader adoption, quality, and innovation across diverse sectors worldwide, with market forces and regulatory developments shaping this dynamic landscape.

Market Snapshot: Genomic Biomarker Market Growth Outlook

In 2024, the Genomic Biomarker Market was valued at USD 4.67 billion, with projections showing expansion to USD 4.99 billion by 2025 and a sustained CAGR of 6.77% through 2030. The market is set to reach USD 6.92 billion by the end of this forecast period. Consistent global demand for personalized medicine and next-generation diagnostics fuels this growth, supported by the integration of high-throughput sequencing and robust informatics platforms. Key industry players are leveraging these technologies to enhance assay development, optimize workflows, and reduce costs.

Scope & Segmentation

This research provides a comprehensive breakdown of the Genomic Biomarker Market across products, technologies, applications, end users, and biomarker categories, as well as extensive regional analysis.

  • Product Types: Instruments, reagents and kits, consumables, library preparation kits, microarray kits, PCR kits, and specialized services, including bioinformatics, custom assay development, and sequencing.
  • Technologies: Mass spectrometry systems (GC-MS, LC-MS/MS, MALDI-TOF), microarray systems (gene expression, protein, SNP arrays), next-generation sequencers (exome, RNA, targeted, and whole genome approaches), and polymerase chain reaction systems (digital PCR, RT-PCR, qPCR).
  • Applications: Diagnostic testing (oncology, pharmacogenomics, infectious diseases, and genetic testing), drug discovery and development (screening, lead optimization, and validation), personalized medicine (companion diagnostics and predictive biomarkers), and basic, clinical, and translational research.
  • End Users: Academic research institutes, contract research organizations, hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies.
  • Biomarker Categories: DNA alterations (copy number variation, point mutations, structural changes), epigenetic signatures (DNA methylation, chromatin accessibility), protein and phosphoproteomic markers, and RNA types (mRNA, lncRNA, miRNA).
  • Geographic Coverage: Americas (including key U.S. states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, and others), and Asia-Pacific (China, India, Japan, Australia, among others).
  • Leading Companies: Thermo Fisher Scientific Inc., Illumina, QIAGEN N.V., Roche Holding AG, Danaher Corporation, Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, and BGI Genomics.

Key Takeaways and Strategic Insights

  • The adoption of advanced sequencing and analytics platforms is enabling faster, more accurate discovery and clinical validation of genomic biomarkers.
  • Collaboration between academia, industry, and contract research organizations is supporting large-scale trials, accelerating market entry, and increasing innovation pipelines.
  • The interplay of global data sharing, harmonized regulatory requirements, and scalable infrastructure is driving clinical integration across diverse geographic regions.
  • Emerging areas such as liquid biopsy, single-cell analysis, and multi-omic integration present robust opportunities for product development and niche market entry.
  • Democratization of research tools and data accessibility is fostering more inclusive innovation, expanding reach in developing and established markets alike.
  • Sustainability initiatives in data security, environmentally responsible manufacturing, and compliance are increasingly integral to leadership strategies and stakeholder trust.

Tariff Impact: Navigating Trade Dynamics

Recent tariff policies have exerted upward cost pressure on imported laboratory instruments and consumables. This has led institutions to reallocate budgets, adopt supply chain resilience strategies, and invest in domestic manufacturing or local partnerships. These measures help mitigate risks, ensure continuity in project execution, and maintain progress despite evolving trade landscapes. Collaborative funding and resource-sharing among international consortia are also being leveraged to manage elevated operational costs and minimize delays in biomarker research and commercialization.

Methodology & Data Sources

This report utilizes extensive secondary research, including a thorough review of scientific journals, regulatory filings, and intellectual property databases, complemented by primary interviews with industry and clinical experts. Insight validation integrates cross-verification and statistical modeling to ensure analytical rigor and robust scenario analysis, with a foundation of quality control and transparent data collection practices.

Why This Report Matters

  • Offers actionable insights tailored for senior decision-makers to drive investment, partnership, and product development strategies in the genomics sector.
  • Helps stakeholders identify shifting market dynamics, technology trajectories, and evolving regulatory frameworks critical for organizational planning and risk management.
  • Enables competitive benchmarking and strategic positioning through comprehensive segmentation and coverage of industry-leading companies and geographies.

Conclusion

The Genomic Biomarker Market is advancing rapidly, propelled by technology, collaboration, and evolving regulation. This report provides senior leaders with a strategic framework for navigating new opportunities, anticipating challenges, and guiding effective decision-making across the genomics landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of CRISPR-based diagnostic assays for rapid point-of-care genomic biomarker detection
5.2. Increasing adoption of liquid biopsy NGS panels for early cancer detection and treatment monitoring
5.3. Integration of AI-driven bioinformatics platforms for real-time genomic biomarker interpretation and insights
5.4. Regulatory approvals accelerating commercialization of companion diagnostic tests in precision oncology
5.5. Expansion of multi-omics assays combining proteomic and genomic biomarker data for personalized therapy guidance
5.6. Implementation of federated learning models to enable secure cross-institutional genomic data sharing and analysis
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Genomic Biomarker Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Mass Spectrometry Systems
8.2.1.1. GC-MS
8.2.1.2. LC-MS/MS
8.2.1.3. MALDI-TOF
8.2.2. Microarray Systems
8.2.2.1. Gene Expression Arrays
8.2.2.2. Protein Arrays
8.2.2.3. Snp Arrays
8.2.3. Pcr Systems
8.2.3.1. Digital PCR
8.2.3.2. qPCR
8.2.3.3. Rt-PCR
8.2.4. Sequencers
8.2.4.1. Next-Generation Sequencers
8.2.4.2. Sanger Sequencers
8.3. Reagents & Kits
8.3.1. Consumables
8.3.1.1. Enzymes
8.3.1.2. Probes & Primers
8.3.2. Kits
8.3.2.1. Library Prep Kits
8.3.2.2. Microarray Kits
8.3.2.3. Pcr Kits
8.4. Services
8.4.1. Bioinformatics Services
8.4.2. Custom Assay Development
8.4.3. Data Analysis Services
8.4.4. Sequencing Services
8.4.4.1. Exome Sequencing
8.4.4.2. RNA Sequencing
8.4.4.3. Targeted Sequencing
8.4.4.4. Whole Genome Sequencing
9. Genomic Biomarker Market, by Technology
9.1. Introduction
9.2. Mass Spectrometry
9.2.1. GC-MS
9.2.2. LC-MS/MS
9.2.3. MALDI-TOF
9.3. Microarray
9.3.1. Gene Expression Arrays
9.3.2. Protein Arrays
9.3.3. SNP Arrays
9.4. Next-Generation Sequencing
9.4.1. Exome Sequencing
9.4.2. RNA Sequencing
9.4.3. Targeted Sequencing
9.4.4. Whole Genome Sequencing
9.5. Polymerase Chain Reaction
9.5.1. Digital PCR
9.5.2. qPCR
9.5.3. RT-PCR
10. Genomic Biomarker Market, by Application
10.1. Introduction
10.2. Diagnostics
10.2.1. Genetic Testing
10.2.2. Infectious Disease Testing
10.2.3. Oncology Diagnostics
10.2.4. Pharmacogenomic Testing
10.3. Drug Discovery & Development
10.3.1. Lead Optimization
10.3.2. Screening
10.3.3. Target Identification
10.3.4. Target Validation
10.4. Personalized Medicine
10.4.1. Companion Diagnostics
10.4.2. Predictive Biomarkers
10.4.3. Stratified Medicine
10.5. Research
10.5.1. Basic Research
10.5.2. Clinical Research
10.5.3. Translational Research
11. Genomic Biomarker Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Contract Research Organizations
11.4. Hospitals & Diagnostic Laboratories
11.5. Pharmaceutical & Biotechnology Companies
12. Genomic Biomarker Market, by Biomarker Type
12.1. Introduction
12.2. DNA
12.2.1. Copy Number Variation
12.2.2. Methylation
12.2.3. Point Mutations
12.2.4. Structural Variations
12.3. Epigenetic
12.3.1. Chromatin Accessibility
12.3.2. DNA Methylation
12.3.3. Histone Modification
12.4. Protein
12.4.1. Phosphoproteomics
12.4.2. Proteomics
12.5. RNA
12.5.1. Lncrna
12.5.2. miRNA
12.5.3. mRNA
13. Americas Genomic Biomarker Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Genomic Biomarker Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Genomic Biomarker Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Illumina, Inc.
16.3.3. QIAGEN N.V.
16.3.4. Roche Holding AG
16.3.5. Danaher Corporation
16.3.6. Abbott Laboratories
16.3.7. Agilent Technologies, Inc.
16.3.8. Bio-Rad Laboratories, Inc.
16.3.9. PerkinElmer, Inc.
16.3.10. BGI Genomics Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GENOMIC BIOMARKER MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GENOMIC BIOMARKER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GENOMIC BIOMARKER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GENOMIC BIOMARKER MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. GENOMIC BIOMARKER MARKET: RESEARCHAI
FIGURE 26. GENOMIC BIOMARKER MARKET: RESEARCHSTATISTICS
FIGURE 27. GENOMIC BIOMARKER MARKET: RESEARCHCONTACTS
FIGURE 28. GENOMIC BIOMARKER MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GENOMIC BIOMARKER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENOMIC BIOMARKER MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GENOMIC BIOMARKER MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GC-MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GC-MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LC-MS/MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LC-MS/MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MALDI-TOF, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MALDI-TOF, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GENE EXPRESSION ARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GENE EXPRESSION ARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN ARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN ARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SNP ARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SNP ARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY QPCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY QPCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RT-PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RT-PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SANGER SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SANGER SEQUENCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LIBRARY PREP KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LIBRARY PREP KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PCR KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PCR KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CUSTOM ASSAY DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CUSTOM ASSAY DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DATA ANALYSIS SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DATA ANALYSIS SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GC-MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GC-MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LC-MS/MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LC-MS/MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MALDI-TOF, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MALDI-TOF, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GENE EXPRESSION ARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GENE EXPRESSION ARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN ARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN ARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SNP ARRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SNP ARRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY QPCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY QPCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RT-PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RT-PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PHARMACOGENOMIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PHARMACOGENOMIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 171. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PREDICTIVE BIOMARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 172. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PREDICTIVE BIOMARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 173. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY STRATIFIED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 174. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY STRATIFIED MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 175. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 176. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 177. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 178. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 179. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 180. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 181. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 182. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 183. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 184. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 185. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 186. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 187. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 190. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 191. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 192. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 193. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 194. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 195. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 196. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 197. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 198. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 199. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 200. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 201. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY COPY NUMBER VARIATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 202. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY COPY NUMBER VARIATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 203. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY METHYLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 204. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY METHYLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 205. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY POINT MUTATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 206. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY POINT MUTATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 207. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY STRUCTURAL VARIATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 208. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY STRUCTURAL VARIATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 209. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DNA, 2018-2024 (USD MILLION)
TABLE 210. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DNA, 2025-2030 (USD MILLION)
TABLE 211. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 212. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 213. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CHROMATIN ACCESSIBILITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 214. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY CHROMATIN ACCESSIBILITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 215. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 216. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY DNA METHYLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 217. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY HISTONE MODIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 218. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY HISTONE MODIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 219. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, 2018-2024 (USD MILLION)
TABLE 220. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, 2025-2030 (USD MILLION)
TABLE 221. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 222. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 223. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PHOSPHOPROTEOMICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 224. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PHOSPHOPROTEOMICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 225. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 226. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEOMICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 227. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, 2018-2024 (USD MILLION)
TABLE 228. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, 2025-2030 (USD MILLION)
TABLE 229. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 230. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 231. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LNCRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 232. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY LNCRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 233. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MIRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 234. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MIRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 235. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 236. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY MRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 237. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA, 2018-2024 (USD MILLION)
TABLE 238. GLOBAL GENOMIC BIOMARKER MARKET SIZE, BY RNA, 2025-2030 (USD MILLION)
TABLE 239. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 242. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 243. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, 2018-2024 (USD MILLION)
TABLE 244. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, 2025-2030 (USD MILLION)
TABLE 245. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2018-2024 (USD MILLION)
TABLE 246. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2025-2030 (USD MILLION)
TABLE 247. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 248. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 249. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2018-2024 (USD MILLION)
TABLE 250. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2025-2030 (USD MILLION)
TABLE 251. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 252. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 253. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 254. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 255. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 256. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 257. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 258. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 259. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2018-2024 (USD MILLION)
TABLE 260. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2025-2030 (USD MILLION)
TABLE 261. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 262. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 263. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 264. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 265. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 266. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 267. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 268. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 269. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 270. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 271. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 274. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 275. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 276. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 277. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 278. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 279. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 280. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 281. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2024 (USD MILLION)
TABLE 284. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY BIOMARKER TYPE, 2025-2030 (USD MILLION)
TABLE 285. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY DNA, 2018-2024 (USD MILLION)
TABLE 286. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY DNA, 2025-2030 (USD MILLION)
TABLE 287. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, 2018-2024 (USD MILLION)
TABLE 288. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY EPIGENETIC, 2025-2030 (USD MILLION)
TABLE 289. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, 2018-2024 (USD MILLION)
TABLE 290. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY PROTEIN, 2025-2030 (USD MILLION)
TABLE 291. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY RNA, 2018-2024 (USD MILLION)
TABLE 292. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY RNA, 2025-2030 (USD MILLION)
TABLE 293. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 294. AMERICAS GENOMIC BIOMARKER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 295. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 298. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 299. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, 2018-2024 (USD MILLION)
TABLE 300. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, 2025-2030 (USD MILLION)
TABLE 301. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2018-2024 (USD MILLION)
TABLE 302. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY SYSTEMS, 2025-2030 (USD MILLION)
TABLE 303. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2018-2024 (USD MILLION)
TABLE 304. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY PCR SYSTEMS, 2025-2030 (USD MILLION)
TABLE 305. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2018-2024 (USD MILLION)
TABLE 306. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCERS, 2025-2030 (USD MILLION)
TABLE 307. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 308. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 309. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 310. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 311. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 312. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 313. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 314. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 315. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2018-2024 (USD MILLION)
TABLE 316. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY SEQUENCING SERVICES, 2025-2030 (USD MILLION)
TABLE 317. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 318. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 319. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 320. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 321. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 322. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 323. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 324. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 325. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 326. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 327. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 328. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 329. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 330. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 331. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 332. UNITED STATES GENOMIC BIOMARKER MARKET SIZE, BY DRUG DISCO

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Genomic Biomarker market report include:
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • QIAGEN N.V.
  • Roche Holding AG
  • Danaher Corporation
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • BGI Genomics Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.99 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.92 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Colorectal Cancer Molecular Diagnostics Market by Technology (Fluorescence in Situ Hybridization, Microarray, Next Generation Sequencing), Product Type (Instruments, Kits Reagents, Software Services), Application, Biomarker, Sample Type, End User - Global Forecast 2025-2030 - Product Image

Colorectal Cancer Molecular Diagnostics Market by Technology (Fluorescence in Situ Hybridization, Microarray, Next Generation Sequencing), Product Type (Instruments, Kits Reagents, Software Services), Application, Biomarker, Sample Type, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Central Nervous System Biomarkers Market by Type (Genomic Biomarkers, Metabolomic Biomarkers, Proteomic Biomarkers), Disease Indication (Neurodegenerative Diseases, Neurodevelopmental Disorders, Psychotic Disorders), Technology, Application, End-User - Global Forecast 2025-2030 - Product Image

Central Nervous System Biomarkers Market by Type (Genomic Biomarkers, Metabolomic Biomarkers, Proteomic Biomarkers), Disease Indication (Neurodegenerative Diseases, Neurodevelopmental Disorders, Psychotic Disorders), Technology, Application, End-User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Genomics Biomarkers Market by Type, by Disease Indication, by Validation, by End- User, and by Region - Product Image

Genomics Biomarkers Market by Type, by Disease Indication, by Validation, by End- User, and by Region

  • Report
  • 200 Pages
  • Global
From
Genomic Biomarker Market Report 2025 - Product Image

Genomic Biomarker Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Genomic Biomarkers Market - Forecasts from 2025 to 2030 - Product Image

Genomic Biomarkers Market - Forecasts from 2025 to 2030

  • Report
  • 146 Pages
  • Global
From

About the Genomic Biomarker Market

Genomic biomarkers are a type of biomarker that are used to identify and measure genetic material in a biological sample. They are used to detect genetic variations that can be used to diagnose and monitor diseases, predict drug response, and identify individuals at risk for certain conditions. Genomic biomarkers are used in a variety of applications, including personalized medicine, drug development, and diagnostics. Genomic biomarkers are typically identified through the analysis of DNA, RNA, and proteins. They can be used to detect genetic variations that are associated with diseases, such as cancer, and to identify individuals at risk for certain conditions. Genomic biomarkers can also be used to predict drug response and to monitor the progression of diseases. The genomic biomarker market is expected to grow significantly in the coming years, driven by advances in technology and the increasing demand for personalized medicine. Companies in the market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Roche. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.